OTCMKTS:QBIO

Q BioMed Stock Forecast, Price & News

$0.81
0.00 (0.00 %)
(As of 07/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.77
$0.84
50-Day Range
$0.79
$0.98
52-Week Range
$0.75
$1.88
Volume38,302 shs
Average Volume41,482 shs
Market Capitalization$22.35 million
P/E RatioN/A
Dividend YieldN/A
Beta2.04
30 days | 90 days | 365 days | Advanced Chart
Receive QBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for Q BioMed and its competitors with MarketBeat's FREE daily newsletter.


Q BioMed logo

About Q BioMed

Q BioMed, Inc. operates as a biomedical acceleration and development company. It focuses on acquiring and in-licensing pre-clinical, clinical-stage and approved life sciences therapeutic products. Its products include Strontium-89, MetastronTM, QBM-001, Uttroside-B, and MAN 01. The company was founded by Enrique Navas on November 22, 2013 and is headquartered in New York, NY.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.68 out of 5 stars

Medical Sector

1675th out of 2,223 stocks

Pharmaceutical Preparations Industry

718th out of 869 stocks

Analyst Opinion: 0.0Community Rank: 3.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Q BioMed (OTCMKTS:QBIO) Frequently Asked Questions

What stocks does MarketBeat like better than Q BioMed?

Wall Street analysts have given Q BioMed a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Q BioMed wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Q BioMed?

Q BioMed saw a increase in short interest in July. As of July 15th, there was short interest totaling 13,100 shares, an increase of 29.7% from the June 30th total of 10,100 shares. Based on an average daily trading volume, of 84,700 shares, the short-interest ratio is currently 0.2 days.
View Q BioMed's Short Interest
.

When is Q BioMed's next earnings date?

Q BioMed is scheduled to release its next quarterly earnings announcement on Wednesday, October 13th 2021.
View our earnings forecast for Q BioMed
.

How were Q BioMed's earnings last quarter?

Q BioMed Inc. (OTCMKTS:QBIO) released its quarterly earnings data on Wednesday, July, 14th. The company reported ($0.08) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.12) by $0.04.
View Q BioMed's earnings history
.

How has Q BioMed's stock been impacted by Coronavirus (COVID-19)?

Q BioMed's stock was trading at $1.5728 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, QBIO stock has decreased by 48.5% and is now trading at $0.81.
View which stocks have been most impacted by COVID-19
.

Who are Q BioMed's key executives?

Q BioMed's management team includes the following people:
  • Denis D. Corin, Chairman, President, CEO, CFO & CAO
  • Ari Jatwes, Finance Director
  • William S. Rosenstadt, Director, Chief Legal Officer & General Counsel
  • David Laskow-Pooley, Scientific Advisor
  • Kristin M. Keller, Chief Commercial Officer

Who are some of Q BioMed's key competitors?

What other stocks do shareholders of Q BioMed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Q BioMed investors own include NVIDIA (NVDA), Micron Technology (MU), Washington Trust Bancorp (WASH), Nokia (NOK), (CGC), Cisco Systems (CSCO), Inovio Pharmaceuticals (INO), Intel (INTC), OPKO Health (OPK) and AT&T (T).

What is Q BioMed's stock symbol?

Q BioMed trades on the OTCMKTS under the ticker symbol "QBIO."

How do I buy shares of Q BioMed?

Shares of QBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Q BioMed's stock price today?

One share of QBIO stock can currently be purchased for approximately $0.81.

How much money does Q BioMed make?

Q BioMed has a market capitalization of $22.35 million and generates $30,000.00 in revenue each year.

How many employees does Q BioMed have?

Q BioMed employs 4 workers across the globe.

What is Q BioMed's official website?

The official website for Q BioMed is www.qbiomed.com.

Where are Q BioMed's headquarters?

Q BioMed is headquartered at 366 MADISON AVENUE 3RD FLOOR, NEW YORK NY, 10017.

How can I contact Q BioMed?

Q BioMed's mailing address is 366 MADISON AVENUE 3RD FLOOR, NEW YORK NY, 10017. The company can be reached via phone at (646) 889-2226.


This page was last updated on 7/31/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.